Update: Syneos Health to Present at the Baird 2020 Global Healthcare Conference at 12:15 p.m. ET Today

MORRISVILLE, N.C., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced that the Company’s presentation at the Baird 2020 Global Healthcare Conference has been rescheduled because of technical issues. Chief Executive Officer Alistair Macdonald and Chief Financial Officer Jason Meggs will now present today at 12:15 p.m. ET.

A live webcast of the event, along with a link to the presentation materials and archived audio replay of the presentation, will be available on the Company’s Investor Relations website at investor.syneoshealth.com.

About Syneos Health
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.

Contacts
   
Investor Relations: Press/Media:
Ronnie Speight Danielle DeForge
Senior Vice President, Investor Relations Executive Director, External Communications
+1 919 745 2745 +1 202 210 5992
Investor.Relations@syneoshealth.com danielle.deforge@syneoshealth.com


 

 

 

Primary Logo

Back to news